Research Article

Taxpas: Epidemiological and Survival Data in Breast Cancer Patients Treated with a Docetaxel-Based Chemotherapy Regimen in South Africa

Table 4

Statistical analyses based on survival curves: TNBC versus N-TNBC.

≤50 years>50 years
Logrank valueHazard ratio (95% confidence interval)Logrank valueHazard ratio

Stage I 0.352 (0.022–5.631) Not calculable
Stage II = Not calculableNot calculable 0.512 (0.053–4.926)
Stage III 0.133 (0.019–0.943)* 0.138 (0.031–0.619)*
Stage IV 0.444 (0.231–0.853)* 0.718 (0.417–1.235)